JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LANGHAM, M. E.
Right arrow Articles by HART, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LANGHAM, M. E.
Right arrow Articles by HART, R. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 179, Issue 1, 47-55, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


ADRENERGIC RESPONSES IN THE HUMAN EYE

MAURICE E. LANGHAM 1, YOSHIAKI KITAZAWA 1, and ROBERT W. HART 1

1 The W. K. Kellogg Foundation Laboratories, The Wilmer Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland and Applied Physics Laboratory, The Johns Hopkins University Silver Spring, Maryland

The responses of the pupil, intraocular pressure and aqueous humor dynamics have been studied. Norepinephrine induced pupil dilatation, decreased intraocular pressure and increased tonographic outflow facility. The responses were dose-dependent. Isoproterenol was without effect on either the pupil or the outflow facility but decreased intraocular pressure. Epinephrine, at low concentrations, decreased intraocular pressure without an increase in outflow facility and without pupil dilatation. At higher concentrations an increase in outflow facility and mydriasis took place. Protriptyline induced potentiation of the ocular response to both endogenously released and exogenously administered norepinephrine: however, it induced little potentiation to epinephrine and none to isoproterenol.

Submitted on November 25, 1970
Accepted on June 3, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.